Koninklijke Philips
Market Cap
€35.2b
Last Updated
2019/10/23 20:37 UTC
Data Sources
Company Financials +
Executive Summary
Koninklijke Philips N.V. operates as a health technology company worldwide.
Snowflake
Fundamentals
Proven track record with adequate balance sheet and pays a dividend.
Similar Companies
Share Price & News
How has Koninklijke Philips's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-0.08%
PHIA
0.2%
NL Medical Equipment
-0.06%
NL Market
1 Year Return
24.9%
PHIA
21.7%
NL Medical Equipment
9.2%
NL Market
Return vs Industry: PHIA exceeded the Dutch Medical Equipment industry which returned 21.7% over the past year.
Return vs Market: PHIA exceeded the Dutch Market which returned 9.2% over the past year.
Shareholder returns
| PHIA | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.08% | 0.2% | -0.06% |
| 30 Day | -10.0% | -2.4% | -0.6% |
| 90 Day | -6.4% | -1.3% | -2.4% |
| 1 Year | 27.8%24.9% | 23.7%21.7% | 14.0%9.2% |
| 3 Year | 51.6%41.3% | 63.5%55.0% | 40.7%25.0% |
| 5 Year | 107.7%80.7% | 119.4%98.6% | 67.1%33.2% |
Price Volatility Vs. Market
How volatile is Koninklijke Philips's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Do You Know What Koninklijke Philips N.V.'s (AMS:PHIA) P/E Ratio Means?2 weeks ago | Simply Wall St
When Should You Buy Koninklijke Philips N.V. (AMS:PHIA)?3 weeks ago | Simply Wall St
Should You Be Pleased About The CEO Pay At Koninklijke Philips N.V.'s (AMS:PHIA)Valuation
Is Koninklijke Philips undervalued compared to its fair value and its price relative to the market?
30.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PHIA (€39.13) is trading below our estimate of fair value (€56.64)
Significantly Below Fair Value: PHIA is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: PHIA is good value based on its PE Ratio (24.7x) compared to the Medical Equipment industry average (32.7x).
PE vs Market: PHIA is poor value based on its PE Ratio (24.7x) compared to the Dutch market (19.3x).
Price to Earnings Growth Ratio
PEG Ratio: PHIA is poor value based on its PEG Ratio (1.5x)
Price to Book Ratio
PB vs Industry: PHIA is good value based on its PB Ratio (3x) compared to the XE Medical Equipment industry average (3.4x).
Next Steps
Future Growth
How is Koninklijke Philips forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
16.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHIA's forecast earnings growth (16.6% per year) is above the savings rate (0.4%).
Earnings vs Market: PHIA's earnings (16.6% per year) are forecast to grow faster than the Dutch market (12.1% per year).
High Growth Earnings: PHIA's earnings are forecast to grow, but not significantly.
Revenue vs Market: PHIA's revenue (4.9% per year) is forecast to grow slower than the Dutch market (6.1% per year).
High Growth Revenue: PHIA's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHIA's Return on Equity is forecast to be low in 3 years time (15.1%).
Next Steps
Past Performance
How has Koninklijke Philips performed over the past 5 years?
29.8%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: PHIA's earnings have grown significantly by 29.8% per year over the past 5 years.
Accelerating Growth: PHIA's earnings growth over the past year (66.7%) exceeds its 5-year average (29.8% per year).
Earnings vs Industry: PHIA earnings growth over the past year (66.7%) exceeded the Medical Equipment industry 5.5%.
Return on Equity
High ROE: PHIA's Return on Equity (12.2%) is considered low.
Return on Assets
ROA vs Industry: PHIA's Return on Assets is below or equal to the Medical Equipment industry average last year.
Return on Capital Employed
ROCE Improving: PHIA has significantly improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is Koninklijke Philips's financial position?
Financial Position Analysis
Short Term Liabilities: PHIA's short term assets (€9.1B) exceeds its short term liabilities (€7.1B)
Long Term Liabilities: PHIA's short term assets (9.1B) exceeds its long term liabilities (7.3B)
Debt to Equity History and Analysis
Debt Level: PHIA's debt to equity ratio (46%) is considered high
Reducing Debt: PHIA's debt to equity ratio has increased from 33.3% to 46% over the past 5 years.
Debt Coverage: PHIA's debt is well covered by operating cash flow (36.8%).
Interest Coverage: PHIA's interest payments on its debt are well covered by EBIT (25.8x coverage).
Balance Sheet
Inventory Level: PHIA has a high level of physical assets or inventory.
Debt Coverage by Assets: PHIA's debt is covered by short term assets (assets are 1.7x debt).
Next Steps
Dividend
What is Koninklijke Philips's current dividend yield, its reliability and sustainability?
2.17%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: PHIA's dividend (2.17%) isn’t notable compared to the bottom 25% of dividend payers in the Dutch market (2.22%).
High Dividend: PHIA's dividend (2.17%) is low compared to the top 25% of dividend payers in the Dutch market (5.93%).
Stable Dividend: PHIA's dividends per share have been stable in the past 10 years.
Growing Dividend: PHIA's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (53.7%), PHIA's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PHIA's dividends in 3 years are forecast to be well covered by earnings (38.2% payout ratio).
Next Steps
Management
What is the CEO of Koninklijke Philips's salary, the management and board of directors tenure and is there insider trading?
3.1yrs
Average management tenure
CEO
Frans van Houten (59yo)
8.5yrs
Tenure
€5,391,265
Compensation
Mr. François Adrianus van Houten, also known as Frans, has been the Chief Executive Officer and Chairman of Management Board of Royal Philips at Philips India Limited since April 2011. Mr. van Houten serve ...
CEO Compensation Analysis
Compensation vs. Market: Frans's total compensation ($USD6.00M) is about average for companies of similar size in the Dutch market ($USD3.94M).
Compensation vs Earnings: Frans's compensation has been consistent with company performance over the past year.
Management Age and Tenure
3.1yrs
Average Tenure
58.5yo
Average Age
Experienced Management: PHIA's management team is considered experienced (3.1 years average tenure).
Board Age and Tenure
4.4yrs
Average Tenure
64yo
Average Age
Experienced Board: PHIA's board of directors are considered experienced (4.4 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Chris Poon (67yo)
Vice-Chairwoman of the Supervisory Board & Secretary
- Tenure: 0yrs
- Compensation: €154.88k
Jeroen Tas (60yo)
Executive VP and Chief Innovation & Strategy Officer
- Tenure: 3.3yrs
Frans van Houten (59yo)
Chairman of the Board of Management & CEO
- Tenure: 8.5yrs
- Compensation: €5.39m
Roy Jakobs (45yo)
Executive VP & Chief Business Leader of Personal Health
- Tenure: 1yrs
Abhijit Bhattacharya (58yo)
Executive VP
- Tenure: 4yrs
- Compensation: €2.60m
Ronald de Jong (52yo)
Executive VP & Chief Human Resources Officer
- Tenure: 2.5yrs
Sean Carney
Chief Design Officer
- Tenure: 7.9yrs
Marnix van Ginneken (46yo)
Executive VP
- Tenure: 1.9yrs
- Compensation: €1.86m
Sophie Bechu (59yo)
Executive VP & Chief of Operations
- Tenure: 3.1yrs
Leandro Mazzoni
Head of Investor Relations
- Tenure: 0.2yrs
Board Members
Orit Gadiesh (68yo)
Member of Supervisory Board
- Tenure: 5.4yrs
- Compensation: €121.25k
Chris Poon (67yo)
Vice-Chairwoman of the Supervisory Board & Secretary
- Tenure: 0yrs
- Compensation: €154.88k
David E. Pyott (66yo)
Member of Supervisory Board
- Tenure: 4.4yrs
- Compensation: €142.25k
Jeroen van der Veer (72yo)
Chairman of the Supervisory Board
- Tenure: 8.6yrs
- Compensation: €179.50k
Paul Stoffels (57yo)
Member of Supervisory Board
- Tenure: 1.2yrs
- Compensation: €46.67k
Neelam Dhawan (60yo)
Member of Supervisory Board
- Tenure: 7.5yrs
- Compensation: €123.75k
A. Harrison (55yo)
Member of Supervisory Board
- Tenure: 1yrs
- Compensation: €42.33k
Liz Doherty (62yo)
Member of Supervisory Board
- Tenure: 0.4yrs
Company Information
Koninklijke Philips N.V.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Koninklijke Philips N.V.
- Ticker: PHIA
- Exchange: ENXTAM
- Founded: 1891
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €35.166b
- Shares outstanding: 898.81m
- Website: https://www.philips.com
Number of Employees
Location
- Koninklijke Philips N.V.
- Philips Center
- Amstelplein 2
- Amsterdam
- Noord-Holland
- 1096 BC
- Netherlands
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| PHIA | XTRA (XETRA Trading Platform) | ADR EACH REP 1 ORD EUR0.20 | DE | EUR | Jan 1980 | |
| PHG | NYSE (New York Stock Exchange) | ADR EACH REP 1 ORD EUR0.20 | US | USD | Jan 1980 | |
| PHIA | DB (Deutsche Boerse AG) | ADR EACH REP 1 ORD EUR0.20 | DE | EUR | Jan 1980 | |
| 0A2M | LSE (London Stock Exchange) | ADR EACH REP 1 ORD EUR0.20 | GB | USD | Jan 1980 | |
| PHI | SWX (SIX Swiss Exchange) | Yes | Common Shares | CH | CHF | Dec 1980 |
| PHI1 | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Dec 1980 |
| PHIA | BIT (Borsa Italiana) | Yes | Common Shares | IT | EUR | Dec 1980 |
| RYLP.F | OTCPK (Pink Sheets LLC) | Yes | Common Shares | US | USD | Dec 1980 |
| PHIA | ENXTAM (Euronext Amsterdam) | Yes | Common Shares | NL | EUR | Dec 1980 |
| 0LNG | LSE (London Stock Exchange) | Yes | Common Shares | GB | EUR | Dec 1980 |
| PHIAA | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Shares | GB | EUR | Dec 1980 |
| PHIA | WBAG (Wiener Boerse AG) | Yes | Common Shares | AT | EUR | Dec 1980 |
| PHIA N | BMV (Bolsa Mexicana de Valores) | Yes | Common Shares | MX | MXN | Dec 1980 |
| PHI1 | XTRA (XETRA Trading Platform) | Yes | Common Shares | DE | EUR | Dec 1980 |
Biography
Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Diagnosis & Treatment, Connected Care & Health Informatics, and Personal Health segments. The company offers ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/23 20:37 |
| End of Day Share Price | 2019/10/23 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.